Prime Medicine PRME
NASDAQ PRME
$3.81 -0.11 (-2.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Prime Medicine (PRME) Preferred Stock Liabilities (2021 - 2022)

Updated

Prime Medicine (PRME) reported Preferred Stock Liabilities of $395.8 million for Q3 2022, unchanged from $395.8 million a year earlier and unchanged from the prior quarter.

Analysis

Prime Medicine (PRME) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends

Dating back to Q3 2021, Prime Medicine's Preferred Stock Liabilities record includes 5 quarters.

  • By year, Preferred Stock Liabilities came in at $31.14 million in FY2020.
  • Per Business Quant data, the three quarters before Q3 2022 came in at $395.8 million (Q2 2022), $395.8 million (Q1 2022) and $395.8 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Prime Medicine 677.89 Mn 56.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 395.80 Mn
Jun 30, 2022 395.80 Mn
Mar 31, 2022 395.80 Mn
Dec 31, 2021 395.80 Mn
Sep 30, 2021 395.80 Mn
API Access

Prime Medicine Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PRME&period=max&api_key=YOUR_API_KEY